TargetMol

SU5408

Product Code:
 
TAR-T4026
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T4026-1mg1mg£140.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4026-1mL1 mL * 10 mM (in DMSO)£282.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4026-5mg5mg£381.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4026-10mg10mg£536.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4026-25mg25mg£816.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4026-50mg50mg£1,083.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4026-100mg100mg£1,420.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
VEGFR2 Kinase Inhibitor I is a potent, cell-permeable inhibitor of the VEGFR2 kinase.
CAS:
15966-93-5
Formula:
C18H18N2O3
Molecular Weight:
310.353
Pathway:
Angiogenesis; Tyrosine Kinase/Adaptors
Purity:
0.9909
SMILES:
CCOC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccccc23)c1C
Target:
VEGFR

References

Sun L, et al. Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kiN/Ase inhibitors that exhibit selectivity toward particular receptor tyrosine kiN/Ases. J Med Chem. 1998 Jul 2;41(14):2588-603.